Free Trial

Omada Health, Inc.'s Quiet Period To Expire on July 16th (NASDAQ:OMDA)

Omada Health logo with Medical background

Omada Health's (NASDAQ:OMDA - Get Free Report) quiet period is set to expire on Wednesday, July 16th. Omada Health had issued 7,900,000 shares in its initial public offering on June 6th. The total size of the offering was $150,100,000 based on an initial share price of $19.00. During Omada Health's quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on OMDA. Wall Street Zen upgraded shares of Omada Health to a "hold" rating in a research report on Monday, June 16th. Barclays initiated coverage on shares of Omada Health in a research report on Tuesday, July 1st. They set an "overweight" rating and a $21.00 price objective for the company. Morgan Stanley initiated coverage on shares of Omada Health in a report on Tuesday, July 1st. They issued an "overweight" rating and a $25.00 target price on the stock. Needham & Company LLC initiated coverage on shares of Omada Health in a report on Tuesday, July 1st. They issued a "buy" rating and a $23.00 target price on the stock. Finally, Evercore ISI lifted their target price on shares of Omada Health from $21.00 to $23.00 and gave the company an "outperform" rating in a report on Wednesday. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $23.86.

View Our Latest Report on OMDA

Omada Health Trading Down 1.4%

Shares of Omada Health stock traded down $0.25 on Friday, hitting $17.67. The company's stock had a trading volume of 505,055 shares, compared to its average volume of 646,052. Omada Health has a 52-week low of $14.14 and a 52-week high of $28.40.

Omada Health Company Profile

(Get Free Report)

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.

Recommended Stories

Should You Invest $1,000 in Omada Health Right Now?

Before you consider Omada Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.

While Omada Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines